DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Koh C, Canini L, Dahari H. et al.
Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial.
Lancet Infect Dis 2015;
15: 1167-1174
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.